NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter

NASDAQ Market News

NEXT STORY
Aptose to Present at the 8th Annual SVB Leerink Global Healthcare Conference
PREV STORY
Interpace Diagnostics Announces First Independent Publication Demonstrating Clinical Utility of BarreGEN®
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Myovant Sciences Announces FDA Approval of ORGOVYX™ (relugolix), the First and Only Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer

author_avatar
NASDAQ Market News

Altimmune Announces Financial Results for the Year Ended December 31, 2020 and Provides a Corporate Update

author_avatar
NASDAQ Market News

Novavax to Present COVID-19 Vaccine Candidate Data at New York Academy of Science

author_avatar
NASDAQ Market News